Yu, X., Liu, J., Qiu, H., Hao, H., Zhu, J., & Peng, S. (2021). Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer. Bosnian Journal of Basic Medical Sciences, 21(2), 198-207. https://doi.org/10.17305/bjbms.2020.4746